CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Short-term efficacy of adalimumab in ulcerative colitis: A multicentre, prospective observational study
DOI 10.1055/s-0033-1347494
Bibliografische Angaben
Nachweis in CareLit
Autor:innenT Molnár, K Farkas, K Palatka, L Lakner, G Hegede, A Szabó, I Rácz, P Miheller, K Lőrinczy, Z Szepes, M Juhász, Z Tóth, Z Gábor, F Zsigmond, F Nagy
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Our aim was to assess the clinical benefit and the tolerability of adalimumab, a fully human monoclonal antibody to tumor necrosis factor (TNF), in patients with ulcerative colitis (UC) at different Hungarian centers. Methods: Patients with active UC, including those who had lost response or developed intolerance to infliximab, were enrolled in a 52-week uncontrolled trial. Patients were treated with adalimumab of 1…
Zitieren
Zitierempfehlung
T Molnár, K Farkas, K Palatka, L Lakner, G Hegede, A Szabó, I Rácz, P Miheller, K Lőrinczy, Z Szepes, M Juhász, Z Tóth, Z Gábor, F Zsigmond, F Nagy (2013) Short-term efficacy of adalimumab in ulcerative colitis: A multicentre, prospective observational study. Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-0033-1347494
Mit CareLit weiterarbeiten